# OnCo record evaxion (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/evaxion/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "evaxion" ;
  schema:name "Evaxion"@en ;
  schema:description "Evaxion uses artificial intelligence to design vaccines against cancer and infections. Its lead cancer vaccine is personalised to each melanoma patient's tumour, and a newer off-the-shelf vaccine targets brain cancer."@en ;
  schema:url <https://onco.cc/companies/evaxion/>, <https://www.evaxion.ai> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.evaxion.ai>, <https://evaxion.ai/news-resources/?press_release_id=11296>, <https://evaxion.ai/news-resources/?press_release_id=11281> ;
  schema:addressCountry "DK" ;
  onco:cancers <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/glioblastoma/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/>, <https://onco.cc/fronts/ai-computation/> ;
  onco:technologies <https://onco.cc/technologies/neoantigen-mrna-vaccine/>, <https://onco.cc/technologies/shared-antigen-vaccine/>, <https://onco.cc/technologies/ai-drug-design/> ;
  onco:trials <https://onco.cc/trials/nct05309421/> .